Clinical Trial Update: A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating regorafenib after standard chemotherapy in Stage III colon cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Stage III (IIIB or IIIC) Colon Cancer | Phase 3 | Status: TERMINATED